Market Overview

Pacira BioSciences Set to Join S&P SmallCap 600

Share:

NEW YORK, Sept. 24, 2019 /PRNewswire/ -- Pacira BioSciences Inc. (NASD: PCRX) will replace Shutterfly Inc. (NASD: SFLY) in the S&P SmallCap 600 effective prior to the open of trading on Monday, September 30. Apollo Global Management Inc. (NYSE:APO) is acquiring Shutterfly in a transaction expected to be completed tomorrow pending final conditions.

Pacira BioSciences provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients. Headquartered in Parsippany, NJ, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Pharmaceuticals Sub-Industry index.

Following is a summary of the change:

S&P SMALLCAP 600 INDEX – September 30, 2019


COMPANY

GICS ECONOMIC SECTOR

GICS SUB-INDUSTRY

ADDED

Pacira
BioSciences

Health Care

Pharmaceuticals

DELETED

Shutterfly

Consumer Discretionary

Internet & Direct
Marketing Retail

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has become home to over 1,000,000 indices across the spectrum of asset classes that have helped define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
index_services@spglobal.com

Media Inquiries
spdji.comms@spglobal.com

Index Governance Inquiries
IGCC@spglobal.com

Cision View original content:http://www.prnewswire.com/news-releases/pacira-biosciences-set-to-join-sp-smallcap-600-300924703.html

SOURCE S&P Dow Jones Indices

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com